European Journal of Cancer
Volume 46, Issue 4 , Pages 818-825, March 2010

WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis

  • Adam J.W. Paige

      Affiliations

    • Ovarian cancer action (HHMT) Research Centre and Section of Molecular Therapeutics, Department of Oncology, Imperial College London Hammersmith Campus, Du Cane Road, London W12 0NN, United Kingdom
    • Corresponding Author InformationCorresponding author: Tel.: +44 207 594 1548; fax: +44 207 594 2129.
    • ,
  • Manuela Zucknick

      Affiliations

    • Centre for Biostatistics, Department of Epidemiology and Public Health, Imperial College London St. Mary’s Campus, London, United Kingdom
    • Department of Biostatistics, German Cancer Research Centre, Heidelberg, Germany
    • ,
  • Szymon Janczar

      Affiliations

    • Ovarian cancer action (HHMT) Research Centre and Section of Molecular Therapeutics, Department of Oncology, Imperial College London Hammersmith Campus, Du Cane Road, London W12 0NN, United Kingdom
    • ,
  • Jim Paul

      Affiliations

    • Clinical Trials Unit, Cancer Research UK Beatson Laboratories, Glasgow, United Kingdom
    • ,
  • Charles A. Mein

      Affiliations

    • Genome Centre, Institute of Cancer and the CR-UK Clinical Centre, Barts and the London, Queen Mary’s School of Dentistry and Medicine, London, United Kingdom
    • ,
  • Karen J. Taylor

      Affiliations

    • Cancer Research UK and University of Edinburgh Cancer Research Centre, Edinburgh, United Kingdom
    • ,
  • Moira Stewart

      Affiliations

    • Cancer Research UK and University of Edinburgh Cancer Research Centre, Edinburgh, United Kingdom
    • ,
  • Charlie Gourley

      Affiliations

    • Cancer Research UK and University of Edinburgh Cancer Research Centre, Edinburgh, United Kingdom
    • ,
  • Sylvia Richardson

      Affiliations

    • Centre for Biostatistics, Department of Epidemiology and Public Health, Imperial College London St. Mary’s Campus, London, United Kingdom
    • ,
  • Timothy Perren

      Affiliations

    • CRUK Clinical Centre, St James’s University Hospital, Leeds, United Kingdom
    • ,
  • Trivadi S. Ganesan

      Affiliations

    • Cancer Institute and Institute of Molecular Medicine, Amrita Institute of Medical Sciences and Research Centre, Kochi, India
    • ,
  • John F. Smyth

      Affiliations

    • Cancer Research UK and University of Edinburgh Cancer Research Centre, Edinburgh, United Kingdom
    • ,
  • Robert Brown

      Affiliations

    • Ovarian cancer action (HHMT) Research Centre and Section of Molecular Therapeutics, Department of Oncology, Imperial College London Hammersmith Campus, Du Cane Road, London W12 0NN, United Kingdom
    • ,
  • Hani Gabra

      Affiliations

    • Ovarian cancer action (HHMT) Research Centre and Section of Molecular Therapeutics, Department of Oncology, Imperial College London Hammersmith Campus, Du Cane Road, London W12 0NN, United Kingdom

Received 2 December 2009; accepted 14 December 2009. published online 14 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(09)00933-2

doi:10.1016/j.ejca.2009.12.021

European Journal of Cancer
Volume 46, Issue 4 , Pages 818-825, March 2010

Article Tools

* Image Usage & Resolution